RUTI: a new chance to shorten the treatment of latent tuberculosis infection (Q36424616)

14 August 2017

1 reference

title

RUTI: a new chance to shorten the treatment of latent tuberculosis infection (English)

1 reference

Pere-Joan Cardona i Iglesias

14 August 2017

0 references

1 reference

series ordinal

1

1 reference

14 August 2017

publication date

20 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

86

1 reference

14 August 2017

issue

3-4

1 reference

14 August 2017

page(s)

273-289

1 reference

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Nonreplicating persistence of mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Disseminated tuberculosis in interferon gamma gene-disrupted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Intragranulomatous necrosis in lungs of mice infected by aerosol with Mycobacterium tuberculosis is related to bacterial load rather than to any one cytokine or T cell type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

M. tuberculosis persistence, latency, and drug tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Formation and resuscitation of "non-culturable" cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Bacterial dormancy and culturability: the role of autocrine growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Replication dynamics of Mycobacterium tuberculosis in chronically infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Cytokines and the Koch phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Towards a 'human-like' model of tuberculosis: intranasal inoculation of LPS induces intragranulomatous lung necrosis in mice infected aerogenically with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Cord factor trehalose 6,6'-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunology of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The mouse as a useful model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

7 January 2021

Immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Alveolobronchiolar Transport Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Human bronchial epithelium controls TH2 responses by TH1-induced, nitric oxide-mediated STAT5 dephosphorylation: implications for the pathogenesis of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

IFN-γ and NO in mycobacterial disease: new jobs for old hands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Macrophage foam cell formation with native low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The macrophage foam cell as a target for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunomodulatory functions of surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Exogenous surfactant changes the phenotype of alveolar macrophages in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Low concentrations of nitric oxide exert a hormetic effect on Mycobacterium tuberculosis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Production of Antibodies against Glycolipids from the Mycobacterium tuberculosis Cell Wall in Aerosol Murine Models of Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

On the nature of Mycobacterium tuberculosis-latent bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

IL-4 in tuberculosis: implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Lung remodeling in pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Basic Mechanisms of Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The Influence of Remaining Live BCG Organisms in Vaccinated Mice on the Maintenance of Immunity to Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

T cell response to Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

pH gradients through colonies of Bacillus cereus and the surrounding agar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Liposomes as protein carriers in immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Mycobacterial antigens induce apoptosis in human purified protein derivative-specific alphabeta T lymphocytes in a concentration-dependent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Advances in antibody-mediated immunity againstMycobacterium tuberculosis: implications for a novel vaccine strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Therapy of tuberculosis in mice by DNA vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Balancing the immune system: Th1 and Th2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Tuberculosis vaccine development: recent progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2006.01.024

1 reference

14 August 2017

1 reference